Driving superior research performance

Across the Phase I-IV clinical research continuum, Frenova is renowned for driving superior research performance. As a company of Fresenius Medical Care North America, the world’s largest provider of dialysis services, Frenova has a team of nephrology experts and access to clinical development resources that make us the leader in renal research. Our primary network comprises more than 183,000 active ESRD patients and 390,000 active CKD patients and is connected with other renal research site networks, making it an indispensable asset for site selection and targeted patient recruitment. Frenova is dedicated to ensuring the people guiding your clinical development program — from our monitors and project managers, to principal investigators and study coordinators — are practiced researchers focused on kidney disease. We’re here to help you design, implement and execute renal research projects of all sizes in all clinical phases.

No other clinical development services provider works with a more intimate understanding of patients affected by kidney disease and its comorbid conditions than we do. When you need to conduct a complete renal clinical program, trust the partner that’s completely renal — Frenova Renal Research.

Renal Phase I-IV Clinical Services:

  • Protocol design and feasibility assessment
  • Project management
  • Site selection, start-up, monitoring and auditing
  • Regulatory documentation and trial master file support
  • Central laboratories
  • Vendor coordination (e.g., institutional review boards)
  • Real-world bioinformatics and analytics


Latest News